- Home
- UROMITEXAN 200MG INJECTION 2ML
UROMITEXAN 200MG INJECTION 2ML Substitute
UROMITEXAN 200MG INJECTION 2ML Substitute
Verified Ingredients and Effects
Composition:
MESNA-200MG
Uses:
<p>UROMITEXAN 200MG INJECTION 2ML is used in the treatment of Ifosfamide-induced hemorrhagic cystitis. The detailed uses of UROMITEXAN 200MG INJECTION 2ML are as follows:</p><ul><li><strong>Prevent chemotherapy-induced bladder toxicity:</strong> UROMITEXAN 200MG INJECTION 2ML is primarily used to reduce the risk of hemorrhagic cystitis (bleeding and inflammation of the bladder) caused by chemotherapy drugs like ifosfamide and cyclophosphamide by neutralizing toxic metabolites.</li><li><strong>Support uroprotection during cancer treatment:</strong> UROMITEXAN 200MG INJECTION 2ML acts as a cytoprotective agent, safeguarding the urinary tract lining without interfering with the anticancer effects of chemotherapy.</li><li><strong>Reduce complications from chemotherapy:</strong> UROMITEXAN 200MG INJECTION 2ML helps prevent painful urination, blood in urine, and bladder irritation, improving patient comfort and reducing the need for treatment interruptions.</li></ul>
Medicinal Benefits:
UROMITEXAN 200MG INJECTION 2ML belongs to a class of medication known as 'chemoprotectant' primarily used to prevent bleeding into the urine by a particular anticancer medicine known as ifosfamide (ifosfamide-induced hemorrhagic cystitis). It also reduces the risk of inflammation and bleeding in the bladder by receiving anti-cancer medication. It contains Mesna, which works by reacting chemically with the urotoxic ifosfamide (anti-cancer medicines) metabolites, resulting in their detoxification. In addition, it binds to other urotoxic metabolites and inhibits their effects on the bladder.
FAQs
UROMITEXAN 200MG INJECTION 2ML is used to treat Ifosfamide-induced hemorrhagic cystitis.
Our body breaks down anticancer agents like ifosfamide or cyclophosphamide to form a chemical known as acrolein, which can harm and irritate the bladder. UROMITEXAN 200MG INJECTION 2ML works by making this natural chemical less harmful or toxic. However, UROMITEXAN 200MG INJECTION 2ML does not change ifosfamide&#039;s anti-cancer effects.
No, UROMITEXAN 200MG INJECTION 2ML should not be taken with an anti-coagulant like warfarin, heparin or coumarin as it might increase the risk of bleeding and lead to serious complications.
An autoimmune disorder is a condition in which the immune system attacks healthy parts of the body and causes pain, swelling, and damage. Some autoimmune disorders are rheumatoid arthritis, systemic lupus erythematosus or nephritis.
Please inform your doctor if you observe any change in the urine colour (like if you have red/pink-coloured urine).
In addition to bladder bleeding in hemorrhagic cystitis, an individual might also experience bladder wall scarring, decreased bladder size (atrophy), severe systemic infection (urosepsis), and urinary obstruction.
UROMITEXAN 200MG INJECTION 2ML is given with ifosfamide or cyclophosphamide to prevent haemorrhagic cystitis which is a serious side effect caused by the toxic metabolite acrolein produced when these drugs are metabolized.
Yes, UROMITEXAN 200MG INJECTION 2ML is compatible with potassium chloride and doxorubicin. Though no interactions were found, it is advised to consult the doctor before taking UROMITEXAN 200MG INJECTION 2ML with potassium chloride and doxorubicin.
No, UROMITEXAN 200MG INJECTION 2ML is not a chemotherapy drug by itself. However, it is used along with chemotherapy drugs like Ifosfamide to prevent haemorrhagic cystitis, a side effect caused by the toxic metabolites of Ifosfamide, such as acrolein.
No, UROMITEXAN 200MG INJECTION 2ML is not cytotoxic. It is used as a chemo protectant, mainly to prevent haemorrhagic cystitis caused by chemotherapy drugs. It protects the bladder from damage by detoxifying toxic metabolites such as acrolein. UROMITEXAN 200MG INJECTION 2ML itself does not have cytotoxic effects, it is administered with cytotoxic drugs.
No, UROMITEXAN 200MG INJECTION 2ML is not a vesicant. Instead, UROMITEXAN 200MG INJECTION 2ML serves as a chemo protectant to safeguard the bladder from toxic metabolites produced by chemotherapy drugs, particularly preventing haemorrhagic cystitis.
The side effects of UROMITEXAN 200MG INJECTION 2ML include headache, nausea, vomiting, fever, diarrhoea, lethargy, flushing (sense of warmth in the face, ears, neck, and trunk), rash, light-headedness, abdominal pain, flu-like symptoms, and injection site reactions. Consult the doctor if any of these symptoms persist or worsen.
